PMID- 34806324 OWN - NLM STAT- MEDLINE DCOM- 20220316 LR - 20240404 IS - 2051-817X (Electronic) IS - 2051-817X (Linking) VI - 9 IP - 22 DP - 2021 Nov TI - Phosphorylation of Lamin A/C at serine 22 modulates Na(v) 1.5 function. PG - e15121 LID - 10.14814/phy2.15121 [doi] LID - e15121 AB - Variants in the LMNA gene, which encodes for Lamin A/C, are associated with cardiac conduction disease (CCD). We previously reported that Lamin A/C variants p.R545H and p.A287Lfs*193, which were identified in CCD patients, decreased peak I(Na) in HEK-293 cells expressing Na(v) 1.5. Decreased peak I(Na) in the cardiac conduction system could account for patients' atrioventricular block. We found that serine 22 (Ser 22) phosphorylation of Lamin A/C was decreased in the p.R545H variant and hypothesized that lamin phosphorylation modulated Na(v) 1.5 activity. To test this hypothesis, we assessed Na(v) 1.5 function in HEK-293 cells co-transfected with LMNA variants or treated with the small molecule LBL1 (lamin-binding ligand 1). LBL1 decreased Ser 22 phosphorylation by 65% but did not affect Na(v) 1.5 function. To test the complete loss of phosphorylation, we generated a version of LMNA with serine 22 converted to alanine 22 (S22A-LMNA); and a version of mutant R545H-LMNA that mimics phosphorylation via serine 22 to aspartic acid 22 substitution (S22D-R545H-LMNA). We found that S22A-LMNA inhibited Lamin-mediated activation of peak I(Na) by 63% and shifted voltage-dependency of steady-state inactivation of Na(v) 1.5. Conversely, S22D-R545H-LMNA abolished the effects of mutant R545H-LMNA on voltage-dependency but not peak I(Na) . We conclude that Lamin A/C Ser 22 phosphorylation can modulate Na(v) 1.5 function and contributes to the mechanism by which R545H-LMNA alters Na(v) 1.5 function. The differential impact of complete versus partial loss of Ser 22 phosphorylation suggests a threshold of phosphorylation that is required for full Na(v) 1.5 modulation. This is the first study to link Lamin A/C phosphorylation to Na(v) 1.5 function. CI - (c) 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. FAU - Olaopa, Michael A AU - Olaopa MA AD - Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, USA. AD - Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. FAU - Ai, Tomohiko AU - Ai T AD - Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. AD - Department of Clinical Laboratory Medicine, Juntendo University, Tokyo, Japan. FAU - Chao, Bo AU - Chao B AD - Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, USA. FAU - Xiao, Xiangshu AU - Xiao X AD - Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, USA. FAU - Vatta, Matteo AU - Vatta M AD - Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. FAU - Habecker, Beth A AU - Habecker BA AUID- ORCID: 0000-0002-4658-8730 AD - Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, USA. LA - eng GR - R01 CA211866/CA/NCI NIH HHS/United States GR - R01 HL093056/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Physiol Rep JT - Physiological reports JID - 101607800 RN - 0 (LMNA protein, human) RN - 0 (Lamin Type A) RN - 0 (NAV1.5 Voltage-Gated Sodium Channel) RN - 0 (SCN5A protein, human) SB - IM MH - Cardiac Conduction System Disease/*genetics/metabolism MH - HEK293 Cells MH - Humans MH - Lamin Type A/*genetics/metabolism MH - Mutation MH - Mutation, Missense MH - NAV1.5 Voltage-Gated Sodium Channel/*metabolism MH - Patch-Clamp Techniques MH - Phosphorylation PMC - PMC8606869 OTO - NOTNLM OT - Lamin phosphorylation OT - Nav1.5 OT - cardiac conduction disease COIS- All authors declare no conflict of interest. EDAT- 2021/11/23 06:00 MHDA- 2022/03/17 06:00 PMCR- 2021/11/21 CRDT- 2021/11/22 07:22 PHST- 2021/10/29 00:00 [revised] PHST- 2021/07/02 00:00 [received] PHST- 2021/10/31 00:00 [accepted] PHST- 2021/11/22 07:22 [entrez] PHST- 2021/11/23 06:00 [pubmed] PHST- 2022/03/17 06:00 [medline] PHST- 2021/11/21 00:00 [pmc-release] AID - PHY215121 [pii] AID - 10.14814/phy2.15121 [doi] PST - ppublish SO - Physiol Rep. 2021 Nov;9(22):e15121. doi: 10.14814/phy2.15121.